MedPath

Tylan 40 Sulfa-G Premix

Registration Number: MAL14070074HA

Approved
Approval ID

c1e209fbeaa92910

Registration Number

MAL14070074HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

25.00 mcg/mLAvailable
Package Size: 25.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

SULFADIMIDINE/SULFAMETHAZINEActive
Monograph: sulfadimidine/sulfamethazine
TYLOSIN PHOSPHATEActive
Monograph: tylosin phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tylan 40 Sulfa-G Premix - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform